Why the study?
Do intravenous human immunoglobulins act as efficacious and well-tolerated steroid-sparing agents in refractory recurrent pericarditis?
Do intravenous human immunoglobulins act as efficacious and well-tolerated steroid-sparing agents in refractory recurrent pericarditis?
Intravenous human immunoglobulins are highlighted as rapidly acting, well-tolerated, and efficacious steroid-sparing agents for managing refractory recurrent pericarditis.
Supports consideration of IVIGs in refractory pericarditis; hypothesis-generating and requires RCTs before practice change.
IVIGs are rapidly acting, well tolerated, and efficacious steroid-sparing agents in refractory pericarditis.
No takes yet. Share an insight, caveat, or question.
Imazio et al. (2015) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: